Are You Losing Fat — or Losing Muscle? InBody 380 Monitoring for Every GLP-1 Patient
On Mounjaro, Wegovy or semaglutide, the weighing scale only tells you that weight went down — not what you lost. At Nirvana Clinic, Greater Noida, every medically supervised GLP-1 patient is tracked on the InBody 380 body composition analyser, so Dr. Manuj Sondhi (MRCP (UK), MD, DNB) can protect your muscle while the medicine reduces your fat.
Quick answer: Studies of GLP-1 medicines show that a meaningful portion of total weight lost can be lean (muscle) mass if treatment is unsupervised. Body composition monitoring with a device like the InBody 380 — combined with adequate protein, strength exercise and doctor-guided dose titration — helps ensure the weight you lose is predominantly fat. This is why measurement is built into Nirvana Clinic’s medical weight-loss programme.
Why the Weighing Scale Misleads You During GLP-1 Treatment
Two patients can both lose 10 kg on the same medicine — and end up in very different places:
| 10 kg lost — what actually changed | Patient A · Supervised | Patient B · Unsupervised |
|---|---|---|
| Fat mass lost | ~8 kg | ~6 kg |
| Muscle (lean) mass lost | ~2 kg | ~4 kg |
| Metabolism after weight loss | Largely preserved | Slowed — regain risk rises |
| Strength, stamina, appearance | Maintained or improved | Weakness, fatigue, “deflated” look |
| What the scale showed | −10 kg | −10 kg |
Illustrative example for patient education, not a promise of individual results. The proportion of fat vs muscle lost varies with protein intake, exercise, age, dose titration and medical supervision.
This muscle-loss risk is real enough that we cover it in detail in our guide on GLP-1 muscle loss and sarcopenia in Indian patients. The InBody 380 is how we detect it early — before it becomes weakness.
What We Track on the InBody 380 at Every Review
| InBody 380 metric | Why it matters on GLP-1 therapy |
|---|---|
| Body fat mass & body fat % | Confirms the medicine is reducing fat, not just total weight. |
| Skeletal muscle mass | The number we protect. A falling trend triggers a protein, exercise and dose review. |
| Visceral fat level | The “dangerous” internal fat linked to diabetes, fatty liver and heart risk — often improves before the mirror does. |
| Segmental lean analysis | Shows whether arms, legs and trunk are losing muscle unevenly — an early warning many clinics never see. |
| Body water balance | Helps separate true fat loss from dehydration, which is common during nausea phases of dose escalation. |
Read more about the scan itself on our dedicated InBody 380 body composition analysis page.
How Monitoring Fits Into Your GLP-1 Treatment Plan
1 · Baseline scan (before first dose)
InBody 380 scan + blood tests + history and examination. Your starting fat, muscle and visceral fat numbers become the reference every future scan is compared against.
2 · Scans during dose titration
Repeat scans at doctor-decided intervals (commonly every 4–8 weeks during titration). We look at the fat-to-muscle ratio of your loss, not just the total.
3 · Course-correction
If muscle mass is falling faster than expected, Dr. Sondhi adjusts the plan — protein targets, resistance exercise guidance, titration pace, or investigation for other causes.
4 · Maintenance & stopping strategy
When treatment goals are reached, composition data guides the tapering or continuation decision — one of the biggest factors in avoiding rapid regain after stopping.
Scan frequency is individualised by the doctor; the intervals above are typical, not fixed.
Supervised by Dr. Manuj Sondhi
MRCP (UK), MD, DNB · Consultant Physician & Diabetologist
Dr. Sondhi leads the diabetes, metabolic health and medical weight-loss services at Nirvana Clinic, Greater Noida, and is a Visiting Consultant at Fortis Hospital, Greater Noida. GLP-1 medicines in his practice are prescription-only, titrated gradually, and always paired with objective measurement — because “the scale went down” is not the same as “you got healthier”.
📍 GF-93, Ground Floor, Sun Twilight Complex, opposite Delta-1 Metro Station, Greater Noida 201308
Part of our GLP-1 patient guide series: start with the complete GLP-1 therapy in India guide, then see muscle loss & sarcopenia on GLP-1, the Mounjaro/Wegovy diet guide and managing GLP-1 side effects.
Frequently Asked Questions
Do GLP-1 medicines like Mounjaro and Wegovy cause muscle loss?
Any significant weight loss includes some lean mass, and studies of GLP-1 medicines show muscle can form a meaningful part of the total weight lost, especially without adequate protein and strength exercise. Supervised treatment with body composition monitoring helps keep the loss predominantly fat.
What is an InBody 380 scan and does it hurt?
The InBody 380 is a medical-grade body composition analyser. You stand on the device holding hand electrodes for under a minute while it measures fat mass, skeletal muscle mass, visceral fat level and body water. It is painless, radiation-free and done in-clinic at Nirvana Clinic, Greater Noida.
How often should body composition be checked during GLP-1 treatment?
A baseline scan before starting, then repeat scans at doctor-decided intervals — commonly every 4 to 8 weeks during dose titration and less frequently in maintenance. Your doctor individualises the schedule based on your progress and results.
Can I get an InBody scan if I started GLP-1 treatment elsewhere?
Yes. Patients already on Mounjaro, Wegovy or semaglutide from another prescriber can book a consultation with an InBody 380 assessment at Nirvana Clinic to check whether their loss is fat or muscle, and to bring their treatment under structured monitoring.
What happens if my scan shows I am losing muscle?
The plan is adjusted rather than the medicine simply continued blindly — typically higher protein targets, structured resistance exercise, review of titration pace, and checking for other contributors like inadequate calories or vitamin D deficiency. A follow-up scan then confirms the correction worked.
Is visceral fat different from normal body fat?
Yes. Visceral fat sits around internal organs and is more strongly linked to type 2 diabetes, fatty liver and heart disease than fat under the skin. The InBody 380 reports a visceral fat level at every scan, and reducing it is one of the most important health goals of medically supervised weight loss.
Is the InBody scan a substitute for blood tests?
No. Body composition scans and blood tests answer different questions and are used together. Blood tests track sugar, liver, kidney and nutritional status; the InBody scan tracks what your body is physically made of. GLP-1 monitoring at Nirvana Clinic uses both.
How do I book a GLP-1 consultation with InBody monitoring in Greater Noida?
Book a consultation with Dr. Manuj Sondhi via WhatsApp at +91 88002 62767 or visit Nirvana Clinic, GF-93, Sun Twilight Complex, opposite Delta-1 Metro Station, Greater Noida. Your first visit includes eligibility assessment, baseline InBody 380 scan and blood tests where needed.
Losing Weight? Make Sure It’s the Right Kind of Weight.
Book a doctor-led GLP-1 consultation with baseline InBody 380 body composition analysis — whether you are starting treatment or already on it.
Related reading: GLP-1 Therapy in India — Complete Guide · InBody 380 Scan · Medical Weight-Loss Programme · GLP-1 Weight-Loss Plateau